Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 3:19 PM ET

Healthcare Equipment and Supplies

Company Overview of ZOLL Medical Corporation

Company Overview

ZOLL Medical Corporation develops and markets medical devices. The company offers defibrillators and monitors, ventilators and aspirators, automated external defibrillators, temperature management systems, fluid resuscitation solutions, and electrodes and batteries. Additionally, it develops medical software. The company also provides customer and technical support solutions. It focuses on healthcare, public safety, military, homeland security, and alternate care. The company was founded in 1980 and is based in Chelmsford, Massachusetts. ZOLL Medical Corporation operates as a subsidiary of Asahi Kasei Corporation.

269 Mill Road

Chelmsford, MA 01824

United States

Founded in 1980

1,908 Employees

Phone:

978-421-9655

Fax:

978-421-0025

Key Executives for ZOLL Medical Corporation

Chief Executive Officer
Age: 57
Senior Vice President of International Operations
Age: 54
Senior Vice President and Vice President of North American Sales
Age: 64
President of ZOLL Data Management Products
Age: 51
President of ZOLL Core Products
Age: 51
Compensation as of Fiscal Year 2015.

ZOLL Medical Corporation Key Developments

ZOLL Medical Corporation Announces New ResQCPR System

ZOLL Medical Corporation announced that its new ResQCPR™ System, which offers new hope for survival from sudden cardiac arrest (SCA), is now available nationwide. Instances of the ResQCPR System helping to save lives are already being reported by early adopters of the technology. The ResQCPR System is a combination of two medical devices, the ResQPUMP® ACD-CPR device and the ResQPOD® Impedance Threshold Device (ITD). The devices are used together during CPR to create an enhanced vacuum in the chest that improves blood flow to the brain and vital organs during states of low blood flow such as cardiac arrest. The device combination was shown in a large clinical trial to improve survival to one year from out-of-hospital, non-traumatic cardiac arrest by 49% when compared to treatment with conventional cardiopulmonary resuscitation (CPR).According to the Food and Drug Administration (FDA), the ResQCPR System is the first and only CPR device indicated to improve the likelihood of survival in adults who have experienced non-traumatic sudden cardiac arrest.

Baku 2015 Equips European Games with ZOLL AED Plus to Treat Sudden Cardiac Arrest

ZOLL Medical Corporation announced that the Baku 2015 European Games, being held 12-28 June in Baku, Azerbaijan, will be equipped with the ZOLL AED Plus in the event that anyone attending or participating in this inaugural edition of the European Games experiences a sudden cardiac arrest. Eighty AED Plus units will be distributed among the mobile medical teams and be available across all Baku 2015 venues. According to the Operations Committee of the Baku Games, the AED Plus was recommended because of its CPR feedback technology. In addition to providing a shock if needed, the AED Plus features Real CPR Help technology, real-time audio and visual feedback to guide rescuers to the correct depth and rate of chest compression to deliver high-quality CPR and positively impact outcomes.

Opto Circuits Wins $23 Million in a Case Against Zoll

Opto Circuits (India) Ltd. has informed in a filing to BSE that its group company Cardiac Science Corporation has won a long-standing dispute over the company's wearable defibrillator technology. A 12-person jury in Los Angeles Superior Court has unanimously decided in favour of the company's breach of contract claims against Zoll Medical Corporation, and Zoll LifeCor Corporation, awarding Cardiac Science USD 22,991,985 in lost royalties. The dispute relates to the company's patented wearable defibrillator technology. In 2002, LifeCor began marketing its LifeVest product, which infringed a number of Cardiac Science's patents. To avoid infringement claims, LifeCor entered into a cross-license agreement with Cardiac Science and was able to continue selling its device.

Similar Private Companies By Industry

Company Name Region
Parcus Medical, LLC United States
Oscor, Inc. United States
Precision Edge Surgical Products Co, LLC United States
PAVmed Inc. United States
Remon Medical Technologies, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
June 8, 2015
Kyma Medical Technologies Ltd.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ZOLL Medical Corporation, please visit www.zoll.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.